Top Categories
Products
Add Listing
PCLX-001 | Greenfire Bio
Product description
PCLX-001 is a first-in-class NMT1/NMT2 inhibitor currently in Phase 2 clinical trials for refractory colorectal cancer and acute myeloid leukemia (AML).
Greenfire Bio
Frisco, United States (US)
Price:
N/A
Quote request
Message
